Know Cancer

or
forgot password
  • cancer clinical trials in iowa city, IA

  • Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lung Cancer
    Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Sarcoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Colorectal Cancer, Neoplasm Metastasis
    A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Ovarian Neoplasms
    Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Ovarian Neoplasms
    A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Papilloma, Recurrent Respiratory Papillomatosis
    Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    University of Iowa Hospital & Clinics
    Iowa City, Iowa 52242
    Pancreatic Cancer
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Lung Cancer
    Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Kidney Cancer
    Genetic Study of Young Patients With Colorectal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Colorectal Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Breast Cancer
    CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    National Lung Screening Trial (NLST) Screening
    University of Iowa
    Iowa City, Iowa 52242
    Lung Cancer
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Colorectal Cancer, Diarrhea, Neutropenia
    EPO906 in Carcinoid and Other Neuroendocrine Tumors
    University of Iowa Health Care
    Iowa City, Iowa 52242
    Carcinoid, Neuroendocrine Tumors
    Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Prostate Cancer
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Prostate Cancer
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Malignant Mesothelioma
    Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center
    Iowa City, Iowa 52242-1009
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
    University of Iowa Hospital Clinic
    Iowa City, Iowa 52242
    Multiple Myeloma
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    University of Iowa

    Trial Locations
    University of Iowa
    University of Iowa Hospitals and Clinics
    Ovarian Neoplasms
    Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    University of Iowa Hospital Division
    Iowa City, Iowa 52242
    Mantle Cell Lymphoma
    Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Iowa City, Iowa
    Sepsis, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Infection
    Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Vulvar Cancer
    Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Lung Cancer
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Pediatric Hypothalamic Obesity
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Obesity
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    University of Iowa Health Care
    Iowa City, Iowa 52242
    Pain
    Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Anemia, Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Neutropenia
    Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Acute Myeloid Leukemia
    Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Kidney Cancer, Leukemia, Lymphoma, Neuroblastoma, Oral Complications, Sarcoma
    Healing Touch and Relaxation Therapies in Cervical Cancer Patients
    University of Iowa Hospital and Clinics
    Iowa City, Iowa 52242
    Cervix Neoplasms
    Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage II Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Kidney Cancer
    Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Endometrial Cancer
    Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Cervical Cancer
    Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
    Univ. Of Iowa Holden Cancer Center
    Iowa City, Iowa 52242
    Carcinoid Tumors
    Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
    University of Iowa
    Iowa City, Iowa 52242
    Ovarian Cancer
    Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Sarcoma
    Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
    University of Iowa Hospitals and Clinics
    Iowa City, Iowa 52242
    Lymphoma, Follicular
    HuMax-CD20 in Chronic Lymphocytic Leukemia
    University of Iowa, Hospitals and Clinics
    Iowa City, Iowa 52242
    Chronic Lymphocytic Leukemia
    Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Gestational Trophoblastic Tumor
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Holden Comprehensive Cancer Center at University of Iowa
    Iowa City, Iowa 52242-1002
    Brain and Central Nervous System Tumors